INNERB SYSTEM
DEAD

Serial Number

97083921

Owner

Aquavit Pharmaceuticals, Inc.

Attorney

Jennifer Bayles

Filing Date

Oct 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INNERB SYSTEM Trademark

Serial Number: 97083921

INNERB SYSTEM is a trademark filed by Aquavit Pharmaceuticals, Inc. on October 20, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Aquavit Pharmaceuticals, Inc. (81 trademarks)

16th Floor
New York, NY 10017

Entity Type: 03

Trademark Details

Filing Date

October 20, 2021

Registration Date

Not Registered

Published for Opposition

January 18, 2022

Goods & Services

Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, general medical and dermatological conditions, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Sunburn preparations for pharmaceutical purposes

Cosmetic skin care services, namely, Non-invasive cosmetic skincare services, chemical peels, cosmetic radio frequency skin tightening procedures, non-surgical body contouring procedures, and fat reduction treatments in the nature of tissue cooling and contouring; providing medical aesthetic procedures, namely, injectable dermal filler treatments to reduce the appearance of fine facial lines; Online cosmetic skincare consultation services

Injection device for pharmaceuticals; Injection instruments with needles; Injection instruments without needles; Injection needles; Injection needles for medical use; Surgical apparatus and instruments; Surgical apparatus and instruments for medical use; Surgical instruments and apparatus; Medical apparatus, namely, infusion and injection devices for administering drugs; Needles for injections; Syringes for injections

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 10, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 10, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2024 EXRA
SOU EXTENSION 5 GRANTED
Aug 12, 2024 EX5G
SOU EXTENSION 5 FILED
Aug 12, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2024 EXRA
SOU EXTENSION 4 GRANTED
Mar 14, 2024 EX4G
SOU EXTENSION 4 FILED
Mar 14, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2023 EXRA
SOU EXTENSION 3 GRANTED
Sep 13, 2023 EX3G
SOU EXTENSION 3 FILED
Sep 13, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2023 EXRA
SOU EXTENSION 2 GRANTED
Mar 14, 2023 EX2G
SOU EXTENSION 2 FILED
Mar 14, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2022 EXRA
SOU EXTENSION 1 GRANTED
Nov 22, 2022 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 21, 2022 AITU
NOTICE OF REVIVAL - E-MAILED
Oct 18, 2022 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 18, 2022 TPEX
PETITION TO REVIVE-GRANTED
Oct 18, 2022 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 18, 2022 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 17, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 17, 2022 ABN6
SOU EXTENSION 1 FILED
Sep 15, 2022 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 10, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 10, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 10, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 10, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 9, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 9, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 8, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2021 NWOS
NEW APPLICATION ENTERED
Oct 23, 2021 NWAP